| P2093 | author name string | Qi Huang | |
| | Yuan Wu | |
| | Xing Wei | |
| | Yuhan Liao | |
| | Meigang Ma | |
| | Hengchang Qi | |
| | Yuejuan Wu | |
| P2860 | cites work | Topography of generalized periodic epileptiform discharges in postanoxic nonconvulsive status epilepticus. | Q51731086 |
| | Repetitive transcranial magnetic stimulation for the treatment of drug-resistant epilepsy: A systematic review and individual participant data meta-analysis of real-world evidence. | Q51733649 |
| | Neurodevelopmental comorbidities and seizure control 24 months after a first unprovoked seizure in children. | Q52589646 |
| | Risk of epilepsy after a single seizure in multiple sclerosis. | Q52669875 |
| | What Happens Next? Recurrence Rates for First Unprovoked Seizures in Children. | Q52732870 |
| | Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. | Q52806824 |
| | Remission of epilepsy as a function of time. | Q53081339 |
| | Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. | Q53500736 |
| | Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice. | Q54209318 |
| | Status epilepticus associated with acute encephalitis: long-term follow-up of functional and cognitive outcomes in 72 patients. | Q54214359 |
| | Autoimmune Epilepsy. | Q55459543 |
| | Epileptic seizures in systemic lupus erythematosus | Q57086591 |
| | Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure | Q74159347 |
| | One vs. Two Years of Anti-epileptic Therapy in Children with Single Small Enhancing CT Lesions | Q79265047 |
| | Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis | Q24620536 |
| | Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). | Q24622393 |
| | Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study | Q24627766 |
| | Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies | Q24642126 |
| | Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype | Q28298099 |
| | Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis | Q28307624 |
| | N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes | Q33882739 |
| | Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. | Q34399975 |
| | GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. | Q34647069 |
| | A clinical approach to diagnosis of autoimmune encephalitis. | Q37343730 |
| | Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy. | Q37696835 |
| | Infectious causes of seizures and epilepsy in the developing world | Q37868785 |
| | Status epilepticus and the use of continuous EEG monitoring in the intensive care unit. | Q38027357 |
| | Anti-NMDAR autoimmune encephalitis | Q38161194 |
| | Antiepileptic drug therapy in patients with autoimmune epilepsy. | Q38691931 |
| | An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China | Q40316125 |
| | Recurrence after a first unprovoked seizure. Is it still a controversial issue? First Seizure Trial Group (first). | Q40742733 |
| | Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient | Q45398845 |
| | Superficial white matter damage in anti-NMDA receptor encephalitis. | Q46001292 |
| | LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. | Q46278362 |
| | Early Recurrence of First Unprovoked Seizures in Children | Q46419441 |
| | Selective Limbic Blood-Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies. | Q47108705 |
| | Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study | Q47446258 |
| | Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis | Q48511419 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | encephalitis | Q199615 |
| | seizure | Q6279182 |
| P304 | page(s) | 1136 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Neurology | Q15817039 |
| P1476 | title | Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis | |
| P478 | volume | 9 | |